The future of paediatric obstructive sleep apnoea assessment: Integrating artificial intelligence, biomarkers, and

Mon Ohn1, Kathleen J Maddison2, Jennifer H Walsh3

  • 1Department of Respiratory and Sleep Medicine, Perth Children's Hospital Nedlands WA Australia; Division of Paediatrics, Medical School, The University of Western Australia, Crawley WA Australia; Perioperative Medicine Team, The Kids Research Institute Australia Nedlands WA Australia; Institute for Paediatric Perioperative Excellence, The University of Western Australia, Crawley WA Australia.

PubMed

Insights

New technologies like AI and wearables offer promising alternatives for screening children with obstructive sleep apnoea (OSA). These methods aim for earlier detection and more accurate diagnosis, addressing limitations of traditional sleep studies.

Area of Science:

  • Pediatric Pulmonology
  • Sleep Medicine
  • Biomedical Engineering

Background:

  • Childhood obstructive sleep apnoea (OSA) diagnosis relies on traditional methods like sleep studies and clinical evaluations.
  • Current diagnostic polysomnography (PSG) is complex and not widely available, leading to a lack of consensus on optimal screening.
  • There is a need for improved, accessible methods for early detection and diagnosis of pediatric OSA.

Purpose of the Study:

  • To review innovative techniques for assessing obstructive sleep apnoea in children.
  • To highlight the potential of new technologies in enhancing diagnostic accuracy for pediatric OSA.
  • To discuss future directions in the assessment of childhood OSA.

Main Methods:

  • Comprehensive literature review of recent advancements in pediatric OSA assessment.
  • Focus on emerging technologies including artificial intelligence (AI), biomarkers, 3D facial photography, and wearable devices.
  • Analysis of how these novel methods overcome limitations of traditional diagnostic approaches.

Main Results:

  • AI, biomarkers, 3D facial photography, and wearable technology show promise for early OSA detection in children.
  • These innovative techniques offer potential improvements in diagnostic accuracy compared to current methods.
  • Emerging biomarkers and technologies could streamline the diagnostic pathway for pediatric OSA.

Conclusions:

  • Advanced technologies and biomarkers represent a significant shift in the approach to diagnosing pediatric OSA.
  • These innovations have the potential to revolutionize clinical practice by improving accessibility and accuracy.
  • Further research and validation are crucial to integrate these novel methods into routine clinical care for childhood OSA.